We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers.
- Authors
Jee-Hye Choi; Ja Kyung Lee; Woochul Kim; Hyeong Won Yu; Su-jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee
- Abstract
Context: The 2015 American Thyroid Association guidelines proposed thyroid lobectomy as an acceptable option for 1- to 4-cm papillary thyroid cancers (PTC) without extrathyroidal extension (ETE) or lymph node (LN) metastasis. However, high-risk features are often detected postoperatively, even in tumors that are considered low risk on preoperative workup. A continued evaluation is necessary to determine the optimal treatment strategies. Objective: We examined the frequency of preoperatively and postoperatively detected high-risk features in 2- to 4-cm PTCs to assess the appropriate surgical extent. Methods: All patients who underwent a thyroid surgery between 2015 and 2020 with a final diagnosis of 2- to 4-cm PTC were selected. Demographics, preoperative findings, perioperative course, and surgical pathology were retrospectively analyzed. Results: Of the entire study cohort (N = 424), 244 (57.5%) patients had at least 1 of the following high-risk features: gross ETE (18.6%), distant metastasis (1.2%), >3 LN involvement with extranodal extension (24.8%), any LN > 3 cm (0.5%), positive margin (13.2%), TERT mutation (2.6%), vascular invasion (10.8%), cN1 disease (28.5%), and > 5 LN involvement (30.4%). Two hundred patients had neither ETE nor LN metastasis on preoperative imaging, but 62/200 (31.0%) were found to have at least 1 of the aforementioned high-risk features on final pathology. Preoperative imaging had sensitivities of 75.9% and 44.4% for detecting gross ETE and LN metastasis, respectively. Conclusion: A significant portion of patients with 2- to 4-cm PTCs, including those who preoperatively met the criteria for lobectomy, were found to have high-risk features on final pathology. Careful patient selection and appropriate counseling are necessary when considering lobectomy for tumors greater than 2 cm.
- Subjects
THYROID cancer; LYMPH nodes; METASTASIS; THYROID gland surgery; CANCER treatment
- Publication
Journal of Clinical Endocrinology & Metabolism, 2022, Vol 107, Issue 10, pe4124
- ISSN
0021-972X
- Publication type
Article
- DOI
10.1210/clinem/dgac457